ViiV Healthcare’s investigational broadly neutralising antibody – N6LS – successfully maintains viral suppression in long-acting treatment of HIV

FHS
March 13, 2025
10:18 am

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Tagomics announces a multiomic profiling co-marketing agreement with Agilent

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools

November 26, 2024

Agilent, Incyte to partner on companion diagnostics

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Diagnostics and instruments company Agilent

January 31, 2024

Qure.ai Raises $65M to Expand Healthcare AI Solutions Globally

What You Should Know: – Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.